(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

KOLMAR

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

KOLMAR

ST13

US500000097363780

Class

5

Filing

97363780

Registration

7404564

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

37

Latest update

03/28/2026

Trademark type

Word

Nice classes

5

Filing date

04/14/2022

Registration date

06/04/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/04/2024

Last transaction

03/28/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

Drawing code

4

Owner type

03

Owner location

SEJONG-SI, KR

Examiner

BUTTON, JENNIFER JO

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

KOLMAR HOLDINGS CO., LTD.
KOLMAR KOREA HOLDINGS CO., LTD.

Representatives

David Youngjoon Jung KAIROS Law Firm, PLLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Nutraceuticals for use as a dietary supplement; nutraceutical preparations for therapeutic or medical purposesnutraceutical preparations for the treatment of immune system related diseases and disordersinfectious diseasesmetabolic diseaseskidney diseasesliver diseasesgastrointestinal diseasesinflammatory diseasescancer and oncologic disordersskin diseases and disorderscardiovascular diseasesrespiratory diseasesallergic diseasesneurological disorders and conditionspsychiatric disorders; dietary supplements; probiotic bacterial formulations for medical use; nutraceutical preparations mainly based on lactic acid bacteria; probiotic preparations for medical use; dietary supplements for humans; lacteal flour for babies; household deodorants; Medicines for human purposesfor the treatment and relief of inflammation and inflammatory diseases and disorders; Medicines for human purposesantioxidants; Medicines for human purposespreparations for the treatment of allergieshay fevermotion sicknessdermatologic usethe treatment of dermatitisskin pigmentation diseasestreatment of cold sorestreatment and prevention of dry skineczemapsoriasisacnefor the treatment of atopic skinthe treatment of sunburnirritated skincrackingcracksinsect bitesminor woundsrasheswartsfor the treatment of diseases and symptoms within the central nervous systemanxietyspasmssleep disordersnervousnessirritabilitynervesapprehensivenessemotional palpitationsfor the treatment of disorders and conditions involving the jointsmusclestendons and ligamentsfor the treatment of joint painmusclemuscle fatiguecrampsfatigue statesfor the treatment of toothachefor the treatment of infections of the mouthfor the treatment of bruisesbumpsachespainfeverheadachesvitamin-based nutritional supplements and mineral supplements; Medicines for human purposesbacterial and bacteriological preparations for medical purposes; disposable baby diapers; vitamin preparations; mineral food supplements; cultures of microorganisms for medical use; Dietetic substancesinfant formula and food for babies adapted for medical use; Dietetic substancesbeverages and food adapted for medical use; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparation for skin care; Pharmaceutical preparations for treatment of hepatitis; Pharmaceutical preparations for the treatment of musculoskeletal disorders; Pharmaceutical preparations for the treatment of diseases of the endocrine system; Pharmaceutical preparations for urogenital organs; Cardiovascular pharmaceutical preparations; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparationsmedicated toiletry preparationsmedicated soapsskin lotions for pharmaceutical purposes; Pharmaceutical preparations for respiratory organs; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceuticalsantioxidants; Pharmaceutical agents affecting digestive organs; Pharmaceuticalsantibiotics and anti-infectives for the treatment and prevention of infectious diseases and obesityfat and cholesterol controlblood sugar control and strengthening of immune system; Pharmaceuticals preparations and substances for the treatment of paininflammationdamaged skin and tissues and wounds; Pharmaceuticals preparations and substances for use in treating dermatitiseczemapsoriasisulcerating woundsskin diseasesskin conditions and lesions; Pharmaceutical skin lotions; probiotic supplements; preparations of microorganisms for medical or veterinary use; nutritional supplements

Publications

History of USPTO decisions and trademark events.

37 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/26/2026

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

03/26/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

03/26/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

03/26/2026

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

06/17/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/17/2025

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

06/17/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/17/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/17/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

06/17/2025

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

06/17/2025

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

06/06/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

06/04/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

06/04/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/19/2024

PUBO

PUBLISHED FOR OPPOSITION

03/19/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/28/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/28/2024

OTHE

CASE RETURNED TO EXAMINATION

01/16/2024

IUCN

NOTICE OF ALLOWANCE CANCELLED

01/16/2024

JURT

JURISDICTION RESTORED TO EXAMINING ATTORNEY

12/07/2023

PCBG

PETITION TO DIRECTOR - CHANGE BASIS - GRANTED

12/07/2023

APET

ASSIGNED TO PETITION STAFF

12/07/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

11/10/2023

EX1G

SOU EXTENSION 1 GRANTED

11/08/2023

EXT1

SOU EXTENSION 1 FILED

11/08/2023

EEXT

SOU TEAS EXTENSION RECEIVED

11/08/2023

EPPA

TEAS POST PUBLICATION AMENDMENT RECEIVED

11/08/2023

TPAD

TEAS PETITION TO AMEND BASIS RECEIVED

11/08/2023

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

05/09/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/14/2023

PUBO

PUBLISHED FOR OPPOSITION

03/14/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/22/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/07/2023

DOCK

ASSIGNED TO EXAMINER

01/31/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/20/2022

NWAP

NEW APPLICATION ENTERED

04/18/2022

Continuous trademark protection

Get notified about every new filing that threatens KOLMAR or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.